APP下载

老年胃食管反流相关性哮喘治疗观察

2016-07-16张成久杨红艳

中国卫生标准管理 2016年6期

李 良 于 丽 张成久 杨红艳



老年胃食管反流相关性哮喘治疗观察

李 良 于 丽 张成久 杨红艳

【摘要】目的 观察老年胃食管反流相关性哮喘治疗的疗效。方法 将74例老年胃食管反流相关性哮喘患者随机分为治疗组37例,对照组37例,两组均予以哮喘常规治疗,对照组给予雷贝拉唑和莫沙比利分散片治疗,治疗组在此基础上加用抗反流治疗。疗程均为8周。结果 治疗组对哮喘的总有效率为89.2%,对照组为62.3%,治疗组对哮喘症状的改善优于对照组(P<0.05)。治疗组对胃食管反流病(GERD)的总有效率为94.6%,对照组为40.5%,治疗组对GERD的改善优于对照组(P<0.01)。治疗组不良反应轻微。结论 雷贝拉唑和莫沙必利分散片治疗老年胃食管反流相关性哮喘不仅能够改善反流症状,也能改善哮喘症状。

【关键词】抗反流治疗;胃食管反流;支气管哮喘

Objective To investigate the effect of elderly gastroesophageal reflux-related asthma. Methods 74 elderly patients with gastroesophageal reflux-

related asthma were randomly divided into treatment group of 37 patients and the control group of 37 patients. Two groups were treated with conventional treatment of asthma. The control group was treated with Mosa Billy and Bella dispersible tablets. On the basis of the control group,the treatment group was treated with anti reflux. The course of treatment was 8 weeks. Results Treatment group asthma of total effective rate was 89.2%,it was better than 62.3% in the control group(P<0.05). The total effective rate of the treatment group for gastroesophageal reflux disease(GERD)was 94.6%,it was better than 40.5% in the control group(P<0.01).Conclusion Rabeprazole and mosapride tablets for gastroesophageal reflux-related asthma can not only improve the reflux symptoms, but also can improve the symptoms of asthma.

【Key words】 Anti-reflux therapy,Gastroesophageal reflux,Bronchial asthma

支气管哮喘患者多合并胃食管反流病(GERD)[1]。研究证实GERD是哮喘的诱因之一,抗反流治疗可以改善哮喘患者的症状。在老年哮喘患者中尤其重要。本文旨在观察雷贝拉唑和莫沙必利分散片对老年胃食管反流相关性哮喘的疗效及安全性。

1 资料与方法

1.1 一般资料

选择2015年1~12月本院门诊和住院的老年支气管哮喘患者74例作为研究对象,GERD的诊断符合中围胃食管反流病共识意见中的诊断标准[2]。其中男40例,女34例,年龄60~75岁,平均年龄(65±5)岁,病程4~17年,平均病程(17±6)年,其中间歇状态6例,轻度持续16例,中度持续18例,重度度持续34例。采用随机数表法分为观察组与对照组,两组年龄、性别、病程、病情严重程度分级等情况基本相似,差异无统计学意义(P >0.05)。……

登录APP查看全文